Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Alimoghaddam, Kamran  [Clear All Filters]
2022
Vaezi M, Souri M, Setarehdan SAmin, Hamidieh AAli, Fazlollahi MReza, Pourpak Z, Badalzadeh M, Tajik S, Mahdaviani SAlireza, Alimoghaddam K, et al. A fludarabine and melphalan reduced-intensity conditioning regimen for HSCT in fifteen chronic granulomatous disease patients and a literature review. Ann Hematol. 2022.
2019
Mousavi SAsadollah, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, Alimoghaddam K, Vaezi M, Fumani HKamranzade, Babakhani D, Tavakoli S. Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran. PLoS One. 2019;14(1):e0208701.
2018
Izadifard M, Pashaiefar H, Yaghmaie M, Montazeri M, Sadraie M, Momeny M, Jalili M, Ahmadvand M, Ghaffari SHamidollah, Mohammadi S, et al. Expression Analysis of PVT1, CCDC26, and CCAT1 Long Noncoding RNAs in Acute Myeloid Leukemia Patients. Genet Test Mol Biomarkers. 2018.
Momeny M, Eyvani H, Barghi F, Ghaffari SH, Javadikooshesh S, Jamadi RH, Esmaeili F, Alishahi Z, Zaghal A, Bashash D, et al. Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells. Anticancer Drugs. 2018.
2016
Eyvani H, Moghaddaskho F, Kabuli M, Zekri A, Momeny M, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Arsenic trioxide induces cell cycle arrest and alters DNA methylation patterns of cell cycle regulatory genes in colorectal cancer cells. Life Sci. 2016.
Hamidieh AA, Hamidi Z, Behfar M, Pajouhi Z, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Sobhani M, Larijani B, Tehrani MRMohajeri. How is the relation between endocrine changes and bone markers in pediatric thalassemic patients after Hematopoietic Stem Cell Transplantation. Minerva Pediatr. 2016.
Dizaji MZaki, Ghaffari SH, Hosseini E, Alizadeh N, Rostami S, Momeny M, Alimoghaddam K, Ghavamzadeh A. Survivin isoform expression in arsenic trioxide-treated acute promyelocytic leukemia cell line and patients: The odd expression pattern of survivin-2α. Asia Pac J Clin Oncol. 2016.
2015
Vaezi M, Bahar B, Mousavi A, Yaghmai M, Kasaeian A, Souri M, Jahani M, Alimoghaddam K, Ghavamzadeh A. Comparison of 60 and 80 mg/m(2) of daunorubicin in induction therapy of acute myeloid leukaemia. Hematol Oncol. 2015.
2014
Hamidieh AAli, Mohajeri-Tehrani MReza, Behfar M, Vaghari-Meher N, Alimoghaddam K, Mohseni F, Ghavamzadeh A, Larijani B, Hamidi Z. Comparison of Bone Mineral Density Changes in Pediatric Thalassemic Patients With and Without Hematopoietic Stem Cell Transplant. Exp Clin Transplant. 2014.
Jalali A, Alimoghaddam K, Mahmoudi M, Mohammad K, Mousavi SAsadollah, Bahar B, Vaezi M, Zeraati H, Jahani M, Ghavamzadeh A. The Effect of GVHD on Long-term Outcomes after Peripheral Blood Allogeneic Stem Cell Transplantation from an HLA-identical Sibling in Adult Acute Lymphocytic Leukemia: A Landmark Analysis Approach in Competing Risks. Int J Hematol Oncol Stem Cell Res. 2014;8(2):1-8.
Alimoghaddam K, Jalali A, Aliabadi LSharifi, Ghaffari F, Maheri R, Eini E, Mashhadireza M, Mousavi SAsadollah, Bahar B, Jahani M, et al. The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience. Int J Hematol Oncol Stem Cell Res. 2014;8(2):9-13.
2013
Ghavamzadeh A, Alimoghaddam K, Ghaffari F, Derakhshandeh R, Jalali A, Jahani M. Twenty years of experience on stem cell transplantation in iran. Iran Red Crescent Med J. 2013;15(2):93-100.